Alembic Pharmaceuticals has reportedly received tentative approval from US Food and Drug Administration (USFDA) for its anti-inflammatory drug. The pharma company has received tentative approval from USFDA for Celecoxib oral capsules, 50 mg, 100mg, 200 mg, 400 mg. GD Searle LLC division of Pfizer Inc is the innovator of this drug. Companies like Teva, Mylan, Watson, Lupin and Apotex have been selling Celecoxib drug, which is one of Pfizer's billion dollar drugs and has a $2 billion size.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.
